about
Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates.Pathophysiology of parkinsonism due to hydrocephalus.Spatial reorganization of putaminal dopamine D2-like receptors in cranial and hand dystoniaA comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-[(11)C]methyl)benperidol.Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys.Robotic preparation of Sodium Acetate C 11 Injection for use in clinical PET.Synthesis and in vivo evaluation of 122I- and 131I-labelled iodoperidol, a potential agent for the tomographic assessment of cerebral perfusion.Binding of 5-(2'-[18F]fluoroethyl)flumazenil to central benzodiazepine receptors measured in living baboon by positron emission tomography.1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine.Specific in vivo binding of 77Br-brombenperidol in rat brain.Radiation dosimetry of [18F] (N-methyl)benperidol as determined by whole-body PET imaging of primates.Metabolism in vitro of radioiodinated N-isopropyl-p-iodoamphetamine by isolated hepatocytes.Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolismAutomated production of oxygen-15 labeled butanol for PET measurement of regional cerebral blood flowThe chemistry of gallium and indium as related to radiopharmaceutical productionSpecific, reversible binding of [18F]benperidol to baboon D2 receptors: PET evaluation of an improved 18F-labeled ligandFirst-pass extraction fraction of iodine-123 labeled perfusion tracers in living primate brain
P50
Q34195302-3F1B0EE4-6A93-4341-AA17-388C072399B6Q34359709-995EBBBA-55D2-431B-A9F1-C4B9A9672500Q35092703-C979CADF-2A05-404B-8267-508190E1139EQ37185341-AAB9CF3E-8A0A-478B-AE10-ABC1A89CF629Q42176761-751CA58A-FC4F-4084-A1EF-AB2F38921E14Q44044350-5AA12050-C41F-4023-88BE-11A9C66A82EAQ48237590-56EFD0D4-CD97-4200-9F19-A03458DA3C56Q48454552-01504BF4-D6C2-4AE0-84DB-CC82AB493292Q48501739-9F3542A6-97E2-49AF-B0B5-616135F5B11AQ48621787-ED5E44C8-DE9C-4EE7-8026-650A45017925Q48710535-8FD89587-007F-4582-ACF9-B42D9C0A9AAEQ51060057-B8B53758-EF80-4467-9D5B-80391A408E03Q68027532-91583E8E-1CC7-4F86-916E-0CBC5B464834Q70484827-B3AD0C68-8A54-45D0-98DB-A0157B1DC8C7Q70564303-8DFF6EDA-F9A0-422E-ADC9-A088BDEEEABEQ70820790-A7F79D72-0AD1-42A0-8DBD-B054FB35E8E3Q73537182-EAE567E2-E082-49F2-B621-C8EF896293FD
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stephen M Moerlein
@ast
Stephen M Moerlein
@en
Stephen M Moerlein
@es
Stephen M Moerlein
@nl
type
label
Stephen M Moerlein
@ast
Stephen M Moerlein
@en
Stephen M Moerlein
@es
Stephen M Moerlein
@nl
prefLabel
Stephen M Moerlein
@ast
Stephen M Moerlein
@en
Stephen M Moerlein
@es
Stephen M Moerlein
@nl
P106
P1153
7003486052
P31
P496
0000-0002-8897-092X